Investors Trendlines Incubators Israel; B. Braun; US based family office
CEO Paul Mraz
ApiFix was acquired by OrthoPediatrics in April 2020 Read more
The unique ApiFix approach provides a viable alternative to failed bracing before considering spinal fusion for many patients as the least invasive spine deformity correction option. The MID-C system acts as an “internal brace” with motion-preserving polyaxial joints and a patented unidirectional, self-adjusting rod mechanism allowing additional post-operative correction over time and is ultimately removable.
The ApiFix device is implanted via a unilateral posterior procedure where patient recovery is relatively pain-free and is measured in days, not months – children are discharged from the hospital in 1-2 days and return to school in 1-2 weeks.
20 issued patents; 7 active patent families (issued and pending)
Certification: FDA, CE mark
Targeted sales: Europe, Canada, Asia
Offices: Boston, Massachusetts, and Misgav, Israel
Founder Dr. Yizhar Floman on ILTV
Founder Uri Arnin presents ApiFix
ApiFix on Israel's Health Channel program, Only Health
25+ years of spine and orthopedic medical device experience; senior/executive-level positions in U.S.- and Israel-based companies, including management, corporate strategy, product development and marketing, sales management — all on a global basis
CEO of Ellipse Technologies from 2011 to 2016, when it was acquired by NuVasive for $410 million
More than 10 years of experience in the spine field; inventor and CTO, Impliant Inc.; founder and CTO, Spine21 Ltd.
Spine surgeon; president of the Israeli Spine Society
Today’s gold standard for correcting spinal deformities involves fusing an average of 10 motion levels using a large number of screws in a surgical procedure that lasts an average of six hours and costs upward of $100,000. Worldwide, there are approximately 126,000 scoliosis procedures per year, of which 40,000 are AIS. The cost of scoliosis correction implants in the United States, not including hospitalization, is around $600 million annually, with an estimated $300 million market outside the United States.